Late-stage research for diabetes and related NCDs receives little funding: evidence from the NIH RePORTER tool  Pascal Geldsetzer, Till Bärnighausen 

Slides:



Advertisements
Similar presentations
Two views of brain function Marcus E. Raichle Trends in Cognitive Sciences Volume 14, Issue 4, Pages (April 2010) DOI: /j.tics
Advertisements

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants The Lancet Volume 387, Issue 10027,
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Venezuela: violence, human rights, and health-care realities
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of.
ZIKA App – A great resource from the World Health Organization (WHO)
Efficacy of carbohydrate counting in type 1 diabetes: a systematic review and meta- analysis  Kirstine J Bell, BNutrDiet, Alan W Barclay, PhD, Peter Petocz,
Thank God for Richard Dawkins?
Fetal growth and ethnic variation
Simple versus complex COPD: implications for health-care management
Mental illness and mental health
Gian Paolo Fadini, Angelo Avogaro  The Lancet Diabetes & Endocrinology 
Germany must invest in its global health academic workforce
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment 
Controlling Ebola: key role of Ebola treatment centres
Infections related to totally implantable venous-access ports
Understanding EMPA-REG OUTCOME
Pycnodysostosis with a patella fracture
John N Nkengasong, Philip Onyebujoh  The Lancet 
Frailty assessment in elderly people
Physical activity and prevention of type 2 diabetes
Underestimate of annual malaria imports to Canada – Author reply
Charity begins at home in global health research funding
Do air quality alerts benefit public health? New evidence from Canada
Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74
Network for strong, national, public health institutes in west Africa
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
Gene therapy—where are we?
Non-uraemic calciphylaxis with acral necrosis
Ana Victoria Roman, Wilton Perez, Richard Smith  The Lancet 
Effective cross-sector collaborations create sustainability
Can famine relief meet health and hunger goals simultaneously?
Understanding EMPA-REG OUTCOME
Disease and stigma The Lancet Volume 354, (December 1999)
Arnaud Chiolero  The Lancet Public Health 
Anthony Rodgers, Alistair Woodward, Boyd Swinburn, William H Dietz 
HIV myths should not be resuscitated
Challenges to eliminate rabies virus infection in China by 2020
Effect of development assistance on domestic health expenditures
Comparing estimates of spending on health and HIV/AIDS
Mina Fazel, DM, Prof Theresa S Betancourt, ScD MA 
Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74
Volume 393, Issue 10171, Pages (February 2019)
Cardiovascular Disease in Women of Reproductive Age
Confessions of a journal junkie
Telling it like it isn't: truth and lies in a post-9/11 world
Support Your Specialty
Thank God for Richard Dawkins?
Low-technology approaches
The emotional journey of gestational diabetes
Does midlife obesity really lower dementia risk?
Muh Geot Wong, Vlado Perkovic  The Lancet Diabetes & Endocrinology 
Thank you to our diverse (but not diverse enough) reviewers
Volume 17, Issue 2, Pages (February 1950)
Vitamin D status and ill health – Author's reply
Fetal growth and ethnic variation
Infections related to totally implantable venous-access ports
Spatial lifecourse epidemiology
Stephen Allison, Tarun Bastiampillai, Doris A Fuller 
A remarkable report card on progress in COPD
Ebola control: rapid diagnostic testing
Difficulties of surgery in the developing world: a personal view
Is Salt a Culprit or an Innocent Bystander in Hypertension
Volume 380, Issue 9846, Pages (September 2012)
Clinic attendance and disengagement of young adults with type 1 diabetes after transition of care from paediatric to adult services (TrACeD): a randomised,
Institutional challenges to achieving health equity in Ecuador
Symptom-based stratification of autoimmune diseases
Sickle cell disease: a new era
Autism, maths, and sex: the special triangle
Reversible biological adaptations in obesity
Presentation transcript:

Late-stage research for diabetes and related NCDs receives little funding: evidence from the NIH RePORTER tool  Pascal Geldsetzer, Till Bärnighausen  The Lancet Diabetes & Endocrinology  Volume 5, Issue 2, Pages 91-92 (February 2017) DOI: 10.1016/S2213-8587(16)30421-1 Copyright © 2017 Elsevier Ltd Terms and Conditions

Figure US National Institutes of Health spending in fiscal year 2016 NCDs=non-communicable diseases, which include cardiovascular and cerebrovascular disease, diabetes, dyslipidemia, hypertension, and obesity. The Lancet Diabetes & Endocrinology 2017 5, 91-92DOI: (10.1016/S2213-8587(16)30421-1) Copyright © 2017 Elsevier Ltd Terms and Conditions